grady-what happened was all the theories that we've been hearing about for the last year, pricing issues, competition, too reliant on Hep C all came true in this latest earnings report. The street sees no catalyst to drive earnings except for a takeover. With that not happening as of now, we have a stock at 89 bucks.
slow down. don't read too much into after hours. remember a few days ago? go have a nice dinner, a shower and a good nights sleep. things will look better tomorrow.
today's action definitely influenced by sarepta. tough stock to own right now as the mid cap biotechs are taking a licking. but I guess that's when you buy em. buy around here and stick with it.
sentiment on BIIB is at it's lowest level in years. I have a feeling that things are not so bad and I think that perhaps some buying will come in late today as the co. reports tomorrow before the open.
no. some data point out today saying china demand for apple phones are very weak. who knows what to believe. yet, the analyst who came out with a note likes nxpi, avgo, crus all with a higher price target. it's all noise. don't do anything based on today's action.
Favus out with negative note on agn. GIVES 10 REASONS TO SELL. who the heck is favus? and it doesn't say what the reasns are. this is from Benzinga-they are not reliable-it's all rumors.
wow, you rarely, and I mean very rarely, see this type of quality analysis and knowledge on a freaking Yahoo message board. Mr. qdelfan, whoever you are, that sure was impressive. After reading your post, I am staying long VRTX. Wow!